Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive perspective. Advocates often highlight the potential for significant therapeutic benefits, especially in ailments where conventional medications have proven inadequate. However, crucially important to consider the considerable financial burden associated with